Active constituents
Greater celandine, like other members of the Papaveraceae (poppy) family, contains
alkaloids as its major constituents. These include chelidoxanthine, chelidonine, and
coptisine. Greater celandine extracts have been shown to stimulate production of bile and
pancreatic digestive enzymes in human studies.5
Animal and test tube studies have shown that the alkaloids and whole plant extract can
relieve gallbladder spasms and stimulate an under-active gallbladder.6 7
Test tube and animal studies have also shown celandine extracts and purified alkaloids to have
anti-inflammatory, anti-cancer and antimicrobial properties.8 9
10 They have also shown greater celandine’s ability to protect animal livers from
toxic substances.11 12
A double-blind trial found that a standardised extract of greater celandine could relieve
symptoms of indigestion (such as abdominal
cramping, sensation of fullness, and nausea) significantly better than a placebo.13
The trial used an extract standardised to 4 mg of chelidonine per capsule and gave 1–2
tablets three times daily for six weeks. An earlier, preliminary trial also found the same
extract reduced symptoms in people with indigestion.14
Preliminary reports from Russia and China have reported that a tincture of greater
celandine applied topically was useful for
warts.15 However, these results have not yet been confirmed by double-blind
clinical trials.
Several reports describe Eastern European clinical trials using semi-synthetic derivatives
of greater celandine alkaloids for people with
cancer.16 This injectable product goes by the name Ukrain®. The findings
on this drug cannot be applied to greater celandine because the alkaloids have been modified
from their original form.
1. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and
Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 84–8.
2. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC
Press, 1985, 113.
3. Mességué M. Of Men and Plants. New York: Macmillian
Co, 1973.
4. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC
Press, 1985, 113.
5. Baumann JC. Effect of Chelidonium, Curcuma, absinth
and Carduus marianus on the bile and pancreatic secretion in liver diseases. Med
Monatsschr 1975;29:173–80 [in German].
6. Hiller KO, Ghorbani M, Schilcher H. Antispasmodic and relaxant
activity of chelidonine, protopine, coptisine, and Chelidonium majus extracts on
isolated guinea-pig ileum. Planta Med 1998;64:758–60 [letter].
7. Hriscu A, Galesanu MR, Moisa L. Cholecystokinetic action of an
alkaloid extract of Chelidonium majus. Rev Med Chir Soc Med Nat Lasi
1980;84:559–61 [in Romanian].
8. Vavreckova C, Gawlik I, Muller K. Benzophenanthridine alkaloids of
Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism.
Planta Med 1996;62:397–401.
9. Sokoloff B, Saelhof CC, Takeuchi Y, Powella R. The antitumor factors
present in Chelidonium majus L. I. Chelidonine and protopine. Growth
1964;28:225–31.
10. Molochko VA, Lastochkina TM, Krylov IA, Brangulis KA. The
antistaphylococcal properties of plant extracts in relation to their prospective use as
therapeutic and prophylactic formulations for the skin. Vestn Dermatol Venerol
1990;(8):54–6 [in Russian].
11. Mitra S, Gole K, Samajdar K, et al. Antihepatotoxic activity of
Chelidonium majus. Int J Pharmacognosy 1992;30:125–8.
12. Mitra S, Sur RK, Roy A, Mukherjee AS. Effect of Chelidonium
majus L on experimental hepatic tissue injury. Phytother Res
1996;10:354–6.
13. Ritter R, Schatton WFH. Clinical trial on standardized celandine
extract in patients with functional epigastric complaints: Results of placebo-controlled
double-blind trial. Comp Ther Med 1993;1:189–93.
14. Kniebel R, Urlacher W. Z Allgemeinmed
1993;69:680–4.
15. Bone K (ed). Chelidonium--A medicinal poppy. MediHerb
Professional Newsletter 1996;49:1–3.
16. Susak YM, Zemskov VS, Yaremchuk OY, et al. Comparison of chemotherapy
and x-ray therapy with Ukrain monotherapy for colorectal cancer. Drugs Exptl Clin Res
1996;22:115–22.
17. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 84–8.
18. Bone K (ed). Chelidonium--A medicinal poppy. MediHerb
Professional Newsletter 1996;49:1–3.
19. Ritter R, Schatton WFH. Clinical trial on standardized celandine
extract in patients with functional epigastric complaints: Results of placebo-controlled
double-blind trial. Comp Ther Med 1993;1:189–93.
20. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 84–8.
21. McGuffin M, Hobbs C, Upton R, Goldberg A (eds). American Herbal
Products Association’s Botanical Safety Handbook. Boca Raton, FL: CRC Press,
1997.
22. Etxenagusia MA, Anda M, Gonzalez-Mahave I, et al. Contact dermatitis
from Chelidonium majus (greater celandine). Contact Derm 2000;43:47.
23. McGuffin M, Hobbs C, Upton R, Goldberg A (eds). American Herbal
Products Association’s Botanical Safety Handbook. Boca Raton, FL: CRC Press,
1997.
24. Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced
by greater celandine (Chelidonium majus). Gastroenterol 1999;117:1234–7.